What does the increasing prevalence of obesity mean for the management of asthma and airways disease?

[Article in English, Portuguese]

Affiliations

Editorial

[Article in English, Portuguese]

Jodie L Simpson et al. J Bras Pneumol. 2020.

. 2020 Mar 2;46(1):e20200048.

doi: 10.1590/1806-3713/e20200048.

¹ . Priority Research Centre for Healthy Lungs, Faculty of Health and Medicine, University of Newcastle, Newcastle, NSW, Australia.

No abstract available

Comment on

Body mass index, asthma, and respiratory symptoms: a population-based study.
Souza ECC, Pizzichini MMM, Dias M, Cunha MJ, Matte DL, Karloh M, Maurici R, Pizzichini E. Souza ECC, et al. J Bras Pneumol. 2019 Dec 20;46(1):e20190006. doi: 10.1590/1806-3713/e20190006. eCollection 2020. J Bras Pneumol. 2019. PMID: 31859815 Free PMC article.

1. Scott HA, Wood LG, Gibson PG. Role of Obesity in Asthma Mechanisms and Management Strategies. Curr Allergy Asthma Rep. 2017;17(8):53–53. doi: 10.1007/s11882-017-0719-9. - DOI - PubMed
1. Camargo CA, Jr, Boulet LP, Sutherland ER, Busse WW, Yancey SW, Emmett AH. Body mass index and response to asthma therapy fluticasone propionate/salmeterol versus montelukast. J Asthma. 2010;47(1):76–82. doi: 10.3109/02770900903338494. - DOI - PubMed
1. Souza ECC, Pizzichini MMM, Dias M, Cunha MJ, Matte DL, Karloh M, Maurici R, Pizzichini E. Body mass index, asthma, and respiratory symptoms a population-based study. J Bras Pneumol. 2020;46(1):e20190006. doi: 10.1590/1806-3713/e20190006. - DOI - PMC - PubMed
1. Scott HA, Gibson PG, Garg ML, Wood LG. Airway inflammation is augmented by obesity and fatty acids in asthma. Eur Respir J. 2011;38(3):594–602. doi: 10.1183/09031936.00139810. - DOI - PubMed
1. Nijhuis J, Rensen SS, Slaats Y, van Dielen FM, Buurman WA, Greve JW. Neutrophil activation in morbid obesity, chronic activation of acute inflammation. Obesity (Silver Spring) 2009;17(11):2014–2018. doi: 10.1038/oby.2009.113. - DOI - PubMed